Quick summary
If you're currently taking Wegovy injections and thinking about switching to oral Wegovy, you're not alone.
Since the oral tablet was approved, plenty of people who've been injecting weekly are asking whether they can move to a daily pill instead. Some are put off by needles, some travel a lot and find a tablet easier to manage, and others are simply curious now that the option exists.
The good news is that switching from Wegovy injections to oral Wegovy is possible—but it should always be done under the guidance of a clinician.
In this guide, we'll explain how switching from Wegovy injections to oral Wegovy works, who might benefit from making the change, and what you can expect once you start treatment.
Can you switch from Wegovy injections to oral Wegovy?
Yes. Wegovy is one of the few GLP-1 medications with a published switching protocol from its manufacturer, Novo Nordisk, covering movement in both directions—injection to tablet, and tablet to injection.¹
Because both forms contain the same active ingredient, semaglutide, switching is a change in how the medication is delivered rather than a change in treatment. That said, the tablet and the injection aren't absorbed in the same way, so it isn't simply a case of taking your injection dose in tablet form.
Because oral absorption is much lower than injection, semaglutide tablets have lower bioavailability than the weekly injection, which delivers the medication directly into your system.¹ Since only a small amount of each pill reaches your bloodstream, there is no direct milligram-to-milligram equivalence between the two formulations, and our Clinical Team will recommend a starting oral dose based on your current injection dose, how you've responded to treatment and whether you've experienced any side effects.
Why do people switch from Wegovy injections to oral Wegovy?
Everyone's weight loss journey is different, and there are several reasons why someone might consider switching formulations.
You'd prefer a tablet over an injection
For many people, the biggest advantage of oral Wegovy is convenience. Rather than injecting once a week, oral Wegovy is taken as a tablet every morning. If you dislike needles, want to avoid injection-site reactions, or find tablets easier to fit around travel and routine, oral Wegovy may feel like a better fit.
You're experiencing side effects
Digestive side effects are common with both formulations, particularly while your body is adjusting to a dose change. These can include:
- Nausea
- Vomiting
- Constipation
- Diarrhoea
- Bloating
- Indigestion
Some people find they tolerate one formulation better than the other, even though the active ingredient is the same.
Our Clinical Team recommends a different approach
Our Clinical Team may suggest switching formulations if:
- you'd prefer to move away from injections for convenience or lifestyle reasons
- you've experienced injection-related side effects, such as site reactions
- your treatment goals have changed
- another formulation may better suit your routine or medical history
The decision should always be based on your individual circumstances rather than weight loss alone.
How does the switch work?
Switching from Wegovy injections to oral Wegovy requires a short washout period. You'll need to wait one week between your last injection and your first tablet—semaglutide stays active in your body for around a week after each dose, so your first tablet is generally due around the time your next injection would have been.
Our Clinical Team will confirm exactly when to take your final injection and when to start your first tablet, and will talk you through your recommended starting dose beforehand.
Never take Wegovy injections and oral Wegovy together, and never combine oral Wegovy with any other GLP-1 medication, such as Mounjaro or Rybelsus.
What dose of oral Wegovy will I start on?
Because there's no direct milligram-to-milligram equivalence between the injection and the tablet, your starting oral dose depends on which injection dose you're currently on. As a general guide:
.png)
If you're on the 7.2 mg injection, it's worth knowing that there currently isn't an oral dose that fully matches that level of exposure—25 mg is the highest licensed oral maintenance dose, so switching from 7.2 mg is likely to feel like a step down in intensity rather than a like-for-like swap. Our Clinical Team can talk you through what to expect if this applies to you.
Depending on your current dose and how well established you are on treatment, our Clinical Team may be able to start you at a higher point on the oral schedule rather than the very first step. This is assessed on an individual basis rather than applied automatically.
How do you take oral Wegovy?
Unlike the injection, which is used once a week, oral Wegovy needs to be taken every day. For the medication to work properly, it's important to follow these instructions:
- Take it first thing in the morning
- Swallow the tablet whole with a small amount of plain water
- Take it on an empty stomach
- Wait at least 30 minutes before eating, drinking anything other than water or taking any other medication³
Taking oral Wegovy correctly helps ensure your body absorbs the medication effectively—missed timing or food too soon afterwards can significantly reduce how much reaches your bloodstream.
Will oral Wegovy work as well as the injection?
Both formulations use semaglutide as their active ingredient, and clinical data supports their long-term effectiveness when combined with healthy lifestyle changes.⁴ ⁵
Looking at the trial data:
- Oral Wegovy (OASIS 4 trial): Within this 64-week study involving 307 participants, the daily pill led to an average overall weight reduction of 13.6%. For those who adhered strictly to the prescribed regimen, the average loss rose to 16.6%, with approximately one-third of the group reducing their total body weight by 20% or more.
- Injectable Wegovy 2.4 mg (STEP 1 trial): Conducted over 68 weeks, this study showed an average weight decrease of 14.9% across the cohort (representing about 15.7 kg from a 105 kg starting point), while the placebo group saw just 2.4%. Among participants who completed the treatment as planned, the average weight loss reached 16.9%.
- Injectable Wegovy 7.2 mg (STEP UP trial): This 72-week study compared the 7.2 mg dose directly with the 2.4 mg version and a placebo. For those who remained on their intended treatment, the 7.2 mg dose achieved an average weight reduction of 20.7%, compared to 17.5% for the 2.4 mg dose. When including all participants regardless of adherence, the 7.2 mg dose averaged an 18.7% loss, versus 15.6% for 2.4 mg and 3.9% for placebo.
To compare the figures directly: the daily tablet typically yields 13.6–16.6% weight loss, the standard weekly injection averages around 14.9%, and the high-dose injection reaches approximately 21%.
Because the body absorbs the tablet less efficiently than the injection, you may notice a slight change in how the medication feels after switching. This is often more apparent if you were previously on a higher injection dose and might include:
- a subtle decrease in appetite suppression
- the occasional return of "food noise"
- a temporary plateau or slowing of weight loss
These adjustments don't indicate that the medication is failing; many patients transition very successfully. However, it is useful to recognize that oral Wegovy can be a slightly less intensive treatment option, particularly when compared to the 7.2 mg high-dose injection.
What should you expect after switching?
The first few weeks after switching often feel similar to when you first started semaglutide, especially if you're stepping down to a lower starting dose than your injection.
You may notice:
- changes in appetite as your body adjusts to the new formulation
- mild digestive symptoms for a week or two
- a short adjustment period before your usual routine settles
Because oral Wegovy needs to be taken daily rather than weekly, many people find that building it into an existing morning routine—alongside brushing their teeth or making coffee—helps it feel effortless quickly.
What side effects can you expect?
The most common side effects of oral Wegovy include:
- nausea
- vomiting
- constipation
- diarrhoea
- stomach pain
- bloating
- indigestion
These side effects are generally mild to moderate and often improve as your body becomes used to the medication.²
Eating smaller meals, staying hydrated and avoiding large, high-fat meals can help reduce digestive symptoms. If your side effects become severe or persistent, you should contact our Clinical Team.
Should you switch?
Whether switching is the right decision depends on your individual circumstances. If you'd prefer a daily tablet, want to avoid injections, or our Clinical Team feels oral Wegovy is a better fit for you, switching may be appropriate.
The most important thing is that any change in formulation is made under clinical supervision, with a starting dose chosen for you individually, so your treatment can continue safely and effectively.
If you're unsure which formulation is right for you, our Clinical Team can help you decide based on your goals, your current dose and your previous treatment experience.
Wegovy is here! Start your free assessment
Switch from injectable to oral Wegovy safely with Habitual
Mounjaro is here! Start your free assessment
References
[1] Wegovy (semaglutide) Summary of Product Characteristics. Novo Nordisk.
[2] Medicines and Healthcare products Regulatory Agency. First GLP-1 tablet for weight loss approved in the UK. Published June 2026.
[3] MHRA. Oral Wegovy prescribing information and administration guidance.
[4] Wharton S, et al. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. New England Journal of Medicine. 2025.
[5] Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.